Aligned Genetics, Inc. (KOSDAQ: 238120)

Market Cap	42.71B
Revenue (ttm)	15.00B
Net Income (ttm)	2.48B
Shares Out	14.38M
EPS (ttm)	125.36
PE Ratio	23.69
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	65,208
Open	3,120.00
Previous Close	3,120.00
Day's Range	2,950.00 - 3,120.00
52-Week Range	2,575.00 - 4,640.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 7, 2025

About Aligned Genetics

Aligned Genetics, Inc. offers cellular imaging and biomolecular analysis solutions worldwide. It also provides molecular diagnostic solutions for rapid results under the Genescale name; and advanced imaging and analysis solutions under the Logos Biosystems name. The company was formerly known as Logos Biosystems, Inc. and changed its name to Aligned Genetics, Inc. in September 2020. Aligned Genetics, Inc. was founded in 2008 and is headquartered in Anyang-Si, South Korea.

• Industry: Laboratory Analytical Instruments
• Founded: 2008
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 238120

Financial Performance

In 2023, Aligned Genetics's revenue was 15.21 billion, an increase of 10.63% compared to the previous year's 13.75 billion. Earnings were 3.24 billion, an increase of 38.72%.